Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01900691 · ClinicalTrials.gov registry record · NA

Removal of the Evolution® Esophageal Stent - Fully Covered

A NA study of Esophageal Neoplasms and Esophageal Stenosis, sponsored by Cook Group Incorporated.

Completed
Registry status
NA
Development phase
130
Enrollment target
11
Study locations

NCT01900691 is a NA study of Esophageal Neoplasms and Esophageal Stenosis that has completed, run by Cook Group Incorporated. The registered enrollment target is 130 participants, below the 1,478-participant average among 12 other Esophageal Neoplasms trials with a reported enrollment target (91% lower). The trial reports 11 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01900691, a NA study of Esophageal Neoplasms and Esophageal Stenosis, has completed, sponsored by Cook Group Incorporated.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
11
Study locations

Study Summary

The CLARITY study is a clinical trial approved by US FDA to study the removal of the Evolution® Esophageal Stent-Fully Covered in malignant and benign indications.

Conditions Studied

Esophageal Neoplasms Esophageal Stenosis Esophageal Fistula Esophageal Perforation Stents

Interventions

  • DEVICE Evolution® Esophageal Stent - Fully Covered

Study Locations (11)

Arizona

  • Mayo Clinic - Phoenix

California

  • Harbor-University of California Los Angeles Medical Center - Torrance

Georgia

  • Emory University Hospital - Atlanta

Illinois

  • Loyola University Medical Center - Maywood

Kentucky

  • University of Louisville, Division of Surgical Oncology - Louisville

Mississippi

  • University of Mississippi Medical Center - Jackson

Ohio

  • Cleveland Clinic - Cleveland

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2013-09
Est. Completion 2018-12-10
Phase NA

Sponsor

Cook Group Incorporated

31 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01900691

The ClinicalTrials.gov registry entry for NCT01900691 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,478-participant average among 12 other Esophageal Neoplasms trials with a reported enrollment target (91% lower). The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Esophageal Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Evolution® Esophageal Stent - Fully Covered is the first listed.

NCT01900691 reports 11 study locations spanning 11 distinct geographic areas - top geographies include Arizona, California, Georgia.

Frequently Asked Questions

What is clinical trial NCT01900691 about?

NCT01900691 is a clinical study titled "Removal of the Evolution® Esophageal Stent - Fully Covered". The CLARITY study is a clinical trial approved by US FDA to study the removal of the Evolution® Esophageal Stent-Fully Covered in malignant and benign indications.

What is the current status of trial NCT01900691?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2013-09. Estimated completion is 2018-12-10.

What conditions does trial NCT01900691 study?

This clinical trial studies the following conditions: Esophageal Neoplasms, Esophageal Stenosis, Esophageal Fistula, Esophageal Perforation, Stents.

What interventions are being tested in trial NCT01900691?

The interventions under investigation include: Evolution® Esophageal Stent - Fully Covered (DEVICE).

Who is sponsoring clinical trial NCT01900691?

This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01900691 being conducted?

This trial has 11 study locations across Arizona, California, Georgia, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Esophageal Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Esophageal Neoplasms

All registered trials for this condition

Esophageal Stenosis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.